PTC Therapeutics
Nasdaq PTCT · Warren, NJ
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Respiratory
PTC Therapeutics is a clinical trial sponsor based in Warren, NJ, listed as Nasdaq PTCT. It has 5 active clinical trials with 394 planned participants, across 13 therapeutic areas. Since 2021 it has completed 15 trials and stopped 7 early.
Trial track record · since 2021
Financials · Nasdaq PTCT
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
3 approved drug applications with a product on the market.
Questions about PTC Therapeutics
PTC Therapeutics is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 394 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 15 trials and stopped 7 early.
PTC Therapeutics is based in Warren, NJ and is listed as Nasdaq PTCT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with PTC Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-08.
Approve Suite is not affiliated with PTC Therapeutics. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.